The Valley Desk

NCT01267253 · Interventional trial

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Overall registry status Completed

Phase 2

Conditions Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Persistent Disease, Recurrent Cervical Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov